Alemtuzumab improves quality of life in relapsing remitting multiple sclerosis patients who relapsed on prior therapy: 3-year follow-up of CARE-MS II

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: ed0f0bf7ca8554f1116353ebf1bbcb421d6535dd
First added on: Apr 30, 2026